ASCML
GILD icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Gilead Sciences GILD Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
130
– – 0.01% 185
2026
Q1 		$18.1K Hold
130
– – 0.02% 172
2025
Q4 		$16K Buy
+130
New +$15.8K 0.02% 176

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's GILD Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its Gilead Sciences (GILD) position steady in Q2 2026 at 130 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #185.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.1K in Q1 2026. 1,323 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 130 shares of Gilead Sciences worth $16.4K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #185 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC's Gilead Sciences position peaked at $18.1K in Q1 2026.
  • 1,323 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.